Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PEB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Thomas Charles Fisher Co-President, C Investmt Ofcr | PEB Pebblebrook Hotel Trust | Sale | 40,000 | $19.25 | $770.0K Sale | Form 4 ↗ |
| Jun 12, 2026 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $18.18 | $363.6K Buy | Form 4 ↗ |
| Jun 11, 2026 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $17.73 | $354.6K Buy | Form 4 ↗ |
| Jun 10, 2026 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $17.23 | $344.6K Buy | Form 4 ↗ |
| Jun 9, 2026 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $17.09 | $341.8K Buy | Form 4 ↗ |
| Jun 8, 2026 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $16.84 | $336.8K Buy | Form 4 ↗ |
| Dec 15, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Sale | 50,000 | $11.26 | $563.0K Sale | Form 4 ↗ |
| Nov 19, 2025 | Michael J. Schall Director | PEB Pebblebrook Hotel Trust | Buy | 10,000 | $10.85 | $108.5K Buy | Form 4 ↗ |
| Aug 19, 2025 | Michael J. Schall Director | PEB Pebblebrook Hotel Trust | Buy | 10,000 | $10.08 | $100.8K Buy | Form 4 ↗ |
| Jun 6, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 5,000 | $9.50 | $47.5K Buy | Form 4 ↗ |
| May 30, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 18,000 | $9.15 | $164.7K Buy | Form 4 ↗ |
| May 27, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 6,000 | $9.00 | $54.0K Buy | Form 4 ↗ |
| May 23, 2025 | Ron E. Jackson Director | PEB Pebblebrook Hotel Trust | Buy | 10,000 | $8.91 | $89.1K Buy | Form 4 ↗ |
| May 22, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 20,000 | $8.99 | $179.8K Buy | Form 4 ↗ |
| May 20, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 23,213 | $9.73 | $225.9K Buy | Form 4 ↗ |
| May 16, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 10,787 | $10.07 | $108.6K Buy | Form 4 ↗ |
| May 7, 2025 | Michael J. Schall Director | PEB Pebblebrook Hotel Trust | Buy | 10,000 | $9.04 | $90.4K Buy | Form 4 ↗ |
| May 7, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 15,000 | $8.97 | $134.6K Buy | Form 4 ↗ |
| May 6, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 42,000 | $8.94 | $375.5K Buy | Form 4 ↗ |
| Mar 24, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 25,000 | $10.45 | $261.3K Buy | Form 4 ↗ |
| Mar 21, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 28,000 | $10.11 | $283.1K Buy | Form 4 ↗ |
| Mar 5, 2025 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 15,000 | $11.91 | $178.7K Buy | Form 4 ↗ |
| Mar 5, 2025 | Michael J. Schall Director | PEB Pebblebrook Hotel Trust | Buy | 10,000 | $11.87 | $118.7K Buy | Form 4 ↗ |
| Nov 21, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 13,000 | $12.68 | $164.8K Buy | Form 4 ↗ |
| Nov 15, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 5,000 | $12.07 | $60.4K Buy | Form 4 ↗ |
| Nov 15, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 2,000 | $12.02 | $24.0K Buy | Form 4 ↗ |
| Nov 14, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Buy | 26,000 | $12.48 | $324.5K Buy | Form 4 ↗ |
| Nov 12, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Sale | 4,000 | $20.00 | $80.0K Sale | Form 4 ↗ |
| Nov 12, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Sale | 4,900 | $22.16 | $108.6K Sale | Form 4 ↗ |
| Nov 12, 2024 | Jon E. Bortz Chairman and CEO, Director | PEB Pebblebrook Hotel Trust | Sale | 2,100 | $22.15 | $46.5K Sale | Form 4 ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances